2m 2m 2m 2m 2m 2m 2m
CRISPR THERAP N (CRSP)
NASDAQ
$55.35-$0.09 (-0.16%)
Price as of Oct 02, 2026 6:28 PM EDT- $5.5BMarket Cap
- -23.87%1-Year Change
- BiotechnologyIndustry
CRISPR THERAP N (CRSP)
$55.35-$0.09 (-0.16%)
CRSP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $55.44 | ||
Change | +$0.12 (+0.22%) | ||
Open | $55.45 | ||
High | $56.59 | ||
Low | $54.82 | ||
Previous Close | $55.32 | ||
Volume | 1,058,270 | ||
30-Day Average Volume | 1,572,781 | ||
1-Week Change | -0.47% | ||
1-Month Change | -2.43% | ||
1-Year Change | -23.87% | ||
3-Year Change | 22.14% | ||
5-Year Change | -50.18% | ||
Fundamentals | |||
Shares Outstanding | 98.6M | ||
Total Assets | $2.7B | ||
Market Cap | $5.5B | ||
Enterprise Value | $5.8B | ||
Period: QTR TTM FY | |||
Revenue | $10.0M | ||
Net Income | -$91.2M | ||
Free Cash Flow | -$84.1M | ||
EBIT | -$86.9M | ||
EBITDA | -$82.6M | ||
Net Working Capital | $2.2B | ||
EPS | -$0.94 | ||
Enterprise Value/EBITDA | -70 | ||
Enterprise Value/Revenue | 576 | ||
P/B | 3 | ||
P/E | -59 | ||
PEG | -2 | ||
Price/Free Cash Flow | -65 | ||
Price/Operating Cash Flow | -65 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue